Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$988,596
+$657,370 QoQ
Shares Held
158,429
+213.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 177 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. MRVI ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in MRVI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $988,596 | 158,429 | Shares | Defined | 2026-08-14 | |
| 2023-12-31 | $331,226 | 50,569 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $196,000 | 19,600 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $340,209 | 27,370 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $306,580 | 21,883 | Principal | Defined | 2023-05-15 | |
| 2021-09-30 | $1,101,846 | 22,450 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $480,186 | 11,507 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $756,921 | 21,238 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||